Researchers have identified a new biomarker in multiple sclerosis (MS): the thickness of the inflammatory rim surrounding ...

TLX101-CDx is an investigational positron emission tomography agent that targets the membrane transport proteins, LAT1 and LAT2.

Researchers at the University of Turku, Finland, have discovered a new biomarker that can predict the progression of multiple ...

A report from the Alzheimer’s Association says new treatments and blood tests could change how doctors detect and treat the ...

The solid cash conversion allows Telix to internally fund organic growth and flexibility to pursue acquisitions. We expect the company to reinvest the majority of earnings into R&D. We forecast ...

New findings from the FACEHBI study show that baseline amyloid PET scans in people with subjective cognitive decline can ...

Conference after conference, Roche scientists running the ongoing Brain Shuttle AD trial of trontinemab are dispensing ...

UC Davis Health's first-of-its-kind total body scanner EXPLORER is being given yet another new assignment—assessing how ...

Neurology experts from UCSF Health presented new clinical research findings and cutting-edge treatment strategies and received distinguished awards recognition at the American Academy of Neurology’s ...

A growing understanding of how “reproductive” hormones sculpt the brain could transform the management of neurological ...